FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

331513007: Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3693138018 Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3693139014 Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3693141010 Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream est un(e) (attribut) Product containing calamine and dimeticone and zinc oxide in cutaneous dose form (medicinal product form) false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream est un(e) (attribut) Product containing only calamine and dimeticone and zinc oxide in cutaneous dose form (medicinal product form) true Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has precise active ingredient Calamine (substance) true Inferred relationship Some 1
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has precise active ingredient oxyde de zinc (substance) true Inferred relationship Some 3
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has basis of strength substance (attribute) oxyde de zinc (substance) true Inferred relationship Some 3
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has basis of strength substance (attribute) Calamine (substance) true Inferred relationship Some 1
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream est un(e) (attribut) Barrier preparation (product) false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream est un(e) (attribut) calamine false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream a pour principe actif (attribut) Dimeticone (substance) false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream a pour principe actif (attribut) oxyde de zinc (substance) false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream a pour principe actif (attribut) Calamine (substance) false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream a pour principe actif (attribut) Pharmaceutical base or inactive agent (substance) false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream a une forme pharmaceutique (attribut) Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream a une forme pharmaceutique (attribut) Cream false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream est un(e) (attribut) Product containing calamine and zinc oxide (medicinal product) false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream est un(e) (attribut) Product containing dimeticone and zinc oxide (medicinal product) false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream a une forme pharmaceutique (attribut) Cutaneous cream true Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream est un(e) (attribut) Product containing calamine in topical dosage form (medicinal product form) false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream est un(e) (attribut) Product containing zinc in topical dosage form (medicinal product form) false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength denominator unit g true Inferred relationship Some 1
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength denominator unit g true Inferred relationship Some 3
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength denominator unit g true Inferred relationship Some 2
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Count of base of active ingredient trois false Inferred relationship Some
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength denominator value un false Inferred relationship Some 1
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength denominator value un false Inferred relationship Some 3
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength denominator value un false Inferred relationship Some 2
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength numerator unit milligram (qualifier value) true Inferred relationship Some 3
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength numerator value (attribute) 75 (qualifier value) false Inferred relationship Some 1
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has precise active ingredient oxyde de zinc (substance) false Inferred relationship Some 1
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has basis of strength substance (attribute) oxyde de zinc (substance) false Inferred relationship Some 1
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has precise active ingredient Calamine (substance) false Inferred relationship Some 3
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has basis of strength substance (attribute) Dimeticone (substance) true Inferred relationship Some 2
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has precise active ingredient Dimeticone (substance) true Inferred relationship Some 2
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength numerator value (attribute) 15 (qualifier value) false Inferred relationship Some 3
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has basis of strength substance (attribute) Calamine (substance) false Inferred relationship Some 3
Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream Has concentration strength numerator value (attribute) 200 (qualifier value) false Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start